Pathogenesis and therapeutic strategy in platinum resistance lung cancer

Lv, PP; Man, SL; Xie, L; Ma, L; Gao, WY

Man, SL (corresponding author), Tianjin Univ Sci & Technol, State Key Lab Food Nutr & Safety,Natl & Local Uni, Key Lab Ind Microbiol,China Int Sci & Technol Coo, Coll Biotechnol,Minist Educ,Tianjin Key Lab Ind M, Tianjin 300457, Peoples R China.; Gao, WY (corresponding author), Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin Key Lab Modern Drug Delivery & High Effic, Tianjin 300072, Peoples R China.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021; 1876 (1):

Abstract

Platinum compounds (cisplatin and carboplatin) represent the most active anticancer agents in clinical use both of lung cancer in mono-and combination......

Full Text Link